Recently, we have received the Supplementary Drug Application Approval from the NMPA for Amoxicillin - Amoxicillin Capsules (0.25 g, 0.5 g) and Greats® - Irbesartan Tablets (75 mg). The products have passed the generic drug consistency evaluation, in
MoreShionogi completed the acquisition of Sumitomo Corporation’s 29% stake in C&O in December 2019. Upon completion of the acquisition, Shionogi became the sole shareholder with shareholding of 100% held in C&O.
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page